glp 1 ads Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ozempic and Other GLP-1s Are

As of now, the FDA has not approved the use of injectable skin lightening or whitening and continues to crack down on unapproved and deceptively labeled drugs that are currently on the market that mislead consumers into thinking otherwise.

Int J Clin Pract 1998

CAGR 16.43% by value and 23.95% by volume through 2031 Novo Nordisk + Eli Lilly combined GLP-1 market share: 57.4% of total peptide therapy market in 2026 a duopoly of extraordinary concentration Oncology Peptide Therapy: 4.1% market share

Consider your budget when making a decision

Product Review NAD Booster Supplements Review (NAD+/NADH, Nicotinamide Riboside, and NMN) How Important Is Boosting NAD+ Levels